Skip to content

Discontinued — last reported Q4 '22

Gross margin at other companies

Pfizer logo
PfizerPFE
73.5%+1.2pp
AbbVie logo
AbbVieABBV
70.7%0.0pp
Incyte logo
IncyteINCY
92.5%-0.2pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
36.7%+4.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
99.3%-0.5pp
Gilead Sciences logo
Gilead SciencesGILD
79.4%+1.1pp

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SELLAS Life Sciences Group, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s gross margin?
SELLAS Life Sciences Group, Inc. (SLS) reported gross margin of 90% in Q4 2022.
How has SELLAS Life Sciences Group, Inc.'s gross margin changed year-over-year?
SELLAS Life Sciences Group, Inc.'s gross margin decreased by 7.6% year-over-year, from 97.4% to 90%.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s gross margin?
Over 2 years (2020 to 2022), SELLAS Life Sciences Group, Inc.'s gross margin has grown at a -5.1% compound annual growth rate (CAGR), from 100% to 90%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.